TY - JOUR
T1 - Five-year experience with Norplant®
AU - Affandi, B.
AU - Santoso, S. S.I.
AU - Djajadilaga,
AU - Hadisaputra, W.
AU - Moeloek, F. A.
AU - Prihartono, J.
AU - Lubis, F.
AU - Samil, R. S.
N1 - Funding Information:
This study was partly supported by the National Family Planning Coordinating Board (BKKBN) Jakarta. The authors wish to thank Mr. Sudjadi B.Sc. from the Department of Public Health, University of Indonesia, Jakarta, for the biostatistical analyses and Dr. Irving Sivin from the Population Council, New York,for the comments and encouragement to publish this paper-
PY - 1987/10
Y1 - 1987/10
N2 - At Klinik Raden Saleh, Department of Obstetrics and Gynaecology, University of Indonesia, from 1 May until 31 August, 1981, Norplant® contraceptive implants were inserted into 437 Indonesian women. The continuation rates of Norplant® at first, second, third, fourth and fifth year were, respectively, 96%, 92%, 88%, 82% and 78%. Bleeding problems were the most common cause for removal. The cumulative five-year net pregnancy rate for Norplant®was 1.8 per 100 women. The Norplant® contraceptive system is thus seen to combine the highest acceptability as measured by its continuation rate with the highest long-term effectiveness among the available temporary contraceptive methods.
AB - At Klinik Raden Saleh, Department of Obstetrics and Gynaecology, University of Indonesia, from 1 May until 31 August, 1981, Norplant® contraceptive implants were inserted into 437 Indonesian women. The continuation rates of Norplant® at first, second, third, fourth and fifth year were, respectively, 96%, 92%, 88%, 82% and 78%. Bleeding problems were the most common cause for removal. The cumulative five-year net pregnancy rate for Norplant®was 1.8 per 100 women. The Norplant® contraceptive system is thus seen to combine the highest acceptability as measured by its continuation rate with the highest long-term effectiveness among the available temporary contraceptive methods.
UR - http://www.scopus.com/inward/record.url?scp=0023576781&partnerID=8YFLogxK
U2 - 10.1016/0010-7824(87)90090-4
DO - 10.1016/0010-7824(87)90090-4
M3 - Article
C2 - 3127111
AN - SCOPUS:0023576781
VL - 36
SP - 417
EP - 428
JO - Contraception
JF - Contraception
SN - 0010-7824
IS - 4
ER -